SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies informs about allotment of ESOP

03 Feb 2026 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that the Nomination and Remuneration Committee of the Company, in its meeting held today, 03rd February, 2026 has approved the allotment of 55,700 equity shares of face value of Rs 2 each to the Indoco Employees Welfare Trust (ESOP Trust) under Indoco Remedies Limited Employee Stock Option Plan - 2022 (Plan). The shares allotted to the ESOP Trust shall be allocated/ transferred to the Eligible Employees upon Exercise of Options and RSUs. Consequent to this allotment, the paid-up capital of the Company stands increased from to Rs. 18,44,95,810 (consisting of 9,22,47,905 equity shares of face value of Rs. 2 each) to Rs. 18,46,07,210 (consisting of 9,23,03,605 equity shares of face value of Rs 2 each). The Nomination and Remuneration Meeting commenced today at 09:00 a.m. and concluded at 09:30 am. Details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are enclosed as Annexure A. 

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

206.50 -7.55 (-3.53%)
24-Apr-2026 15:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.50
Dr. Reddys Lab 1317.80
Cipla 1294.20
Zydus Lifesciences 926.85
Lupin 2294.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×